Latest filings (excl ownership)
20-F
2023 FY
Annual report (foreign)
5 Mar 24
6-K
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
5 Mar 24
6-K
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
10 Jan 24
6-K
Index to Consolidated Financial Statements
7 Nov 23
6-K
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting edge science
18 Oct 23
6-K
Current report (foreign)
14 Aug 23
6-K
Current report (foreign)
8 Aug 23
424B5
Prospectus supplement for primary offering
8 Aug 23
6-K
Index to Consolidated Financial Statements
8 Aug 23
6-K
Current report (foreign)
27 Jun 23
6-K
SOPHiA GENETICS Publishes Results of 2023 Annual General Meeting
26 Jun 23
6-K
Current report (foreign)
6 Jun 23
6-K
SOPHiA GENETICS Announces Nomination of Lila Tretikov to Board of Directors
31 May 23
UPLOAD
Letter from SEC
18 May 23
6-K
Invitation to the Annual General Meeting
17 May 23
CORRESP
Correspondence with SEC
17 May 23
6-K
Current report (foreign)
12 May 23
UPLOAD
Letter from SEC
11 May 23
6-K
Index to Consolidated Financial Statements
9 May 23
6-K
SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis
14 Mar 23
20-F
2022 FY
Annual report (foreign)
7 Mar 23
6-K
SOPHiA GENETICS Reports Fourth Quarter and Year End 2022 Financial Results
7 Mar 23
6-K
SOPHiA GENETICS Expands Partnership with AstraZeneca to include Multimodal Approaches for Cancer Drug Development
13 Feb 23
6-K
Current report (foreign)
10 Jan 23
6-K
Index to Consolidated Financial Statements
8 Nov 22
6-K
SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis
1 Nov 22
6-K
Current report (foreign)
20 Sep 22
6-K
Current report (foreign)
20 Sep 22
EFFECT
Notice of effectiveness
16 Aug 22
CORRESP
Correspondence with SEC
11 Aug 22
UPLOAD
Letter from SEC
11 Aug 22
6-K
Index to Consolidated Financial Statements
9 Aug 22
F-3
Shelf registration (foreign)
9 Aug 22
6-K
Current report (foreign)
15 Jun 22
6-K
Current report (foreign)
15 Jun 22
6-K
SOPHiA GENETICS Achieves CE-IVD Certification using its SOPHiA DDM™ Platform
14 Jun 22
6-K
Invitation to the Annual General Meeting
16 May 22
6-K
Index to Consolidated Financial Statements
10 May 22
6-K
SOPHiA GENETICS Announces Nomination of Jean-Michel Cosséry to Board of Directors
5 May 22
6-K
Current report (foreign)
26 Apr 22
Latest ownership filings
144
Notice of proposed sale of securities
14 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
SC 13G/A
Balderton Capital VI, S.L.P.
20 Feb 24
SC 13G/A
GENERATION INVESTMENT MANAGEMENT LLP
14 Feb 24
SC 13G/A
Balderton Capital VI, S.L.P.
13 Feb 24
144
Notice of proposed sale of securities
6 Sep 23
SC 13D/A
Schindel Yair Chaim
18 May 23
SC 13G/A
GENERATION INVESTMENT MANAGEMENT LLP
13 Feb 23
SC 13D
Schindel Yair Chaim
10 Jan 23
SC 13G/A
GENERATION INVESTMENT MANAGEMENT LLP
15 Feb 22
SC 13G
Coucke Marc
14 Feb 22
SC 13G
Balderton Capital VI, S.L.P.
10 Feb 22
SC 13G
GENERATION INVESTMENT MANAGEMENT LLP
6 Jan 22